Publication:
Serum adiponectin, visfatin, and omentin compared between non-pregnant and pregnant women in overall, non-obese, and obese subjects

dc.contributor.authorChantacha Sitticharoonen_US
dc.contributor.authorXaynaly Souvannavong-Vilivongen_US
dc.contributor.authorRoongrit Klinjampaen_US
dc.contributor.authorMalika Churintaraphanen_US
dc.contributor.authorNay Chi Nwayen_US
dc.contributor.authorIssarawan Keadkraichaiwaten_US
dc.contributor.authorTripop Lertbunnaphongen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherUniversity of Medicine 1en_US
dc.date.accessioned2019-08-28T06:11:13Z
dc.date.available2019-08-28T06:11:13Z
dc.date.issued2018-05-01en_US
dc.description.abstract© 2018, Faculty of Medicine Siriraj Hospital, Mahidol University. Objective: This study aimed to compare serum adiponectin, visfatin, and omentin between non-pregnant and pregnant women in overall, non-obese, and obese subjects. Methods: There were 40 pregnant and 33 non-pregnant women classified by body mass index (BMI) into non-obese or obese subjects. Fasting blood samples were collected in the morning for the non-pregnant group and before delivery for the pregnant group. Results: Plasma glucose levels were significantly lower, but plasma insulin levels were significantly higher in pregnant when compared to non-pregnant women in overall, non-obese, and obese women (p<0.05 all). The homeostasis model assessment of insulin resistance (HOMA-IR) was significantly higher, but the quantitative insulin sensitivity check index (QUICKI) was significantly lower only in obese pregnant when compared to obese non-pregnant women (p<0.01 all). However, in non-obese women, HOMA-IR and QUICKI were comparable between pregnant and non-pregnant women. Serum adiponectin, visfatin, and omentin were significantly lower in pregnant compared to non-pregnant women in overall, non-obese, and obese groups (p<0.05 all). In pregnant women, serum adiponectin and omentin levels were significantly lower in obese compared to non-obese pregnant women while serum visfatin levels were comparable in both groups. Serum adiponectin levels were highest followed by omentin and visfatin, respectively in both non-obese and obese pregnant groups. These results indicated that lower serum adiponectin, visfatin, and omentin in pregnant women might contribute to higher insulin resistance in pregnancy. Furthermore, serum adiponectin and omentin were reduced in increasing adiposity similarly to non-pregnant women. Conclusion: Lower serum adiponectin, visfatin, and omentin in pregnant women might lead to decreased insulin sensitivity in these women.en_US
dc.identifier.citationSiriraj Medical Journal. Vol.70, No.3 (2018), 219-226en_US
dc.identifier.doi10.14456/smj.2018.36en_US
dc.identifier.issn22288082en_US
dc.identifier.other2-s2.0-85051586796en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/46710
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85051586796&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleSerum adiponectin, visfatin, and omentin compared between non-pregnant and pregnant women in overall, non-obese, and obese subjectsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85051586796&origin=inwarden_US

Files

Collections